As of June 19, 2025, IsoRay Inc (ISR) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing IsoRay Inc's Forward P/E to Peers
To better understand IsoRay Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| IsoRay Inc (ISR) | - |
| ADMA Biologics Inc (ADMA) | 28.12 |
| Aptorum Group Ltd (APM) | 0.02 |
Compared to its competitors, IsoRay Inc's Forward P/E is difficult to compare due to insufficient data.